FDA Inspection
Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.) – FDA Inspection, Jul 13, 2018
Record Details
This FDA Inspection record concerns Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.), with an inspection on July 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 13, 2018
- Product Type
- Drugs
View Company Profile
ID · 45638eb1-9784-424d-8940-2b1647abf4f4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061565
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | Not classified | Office of Inspections and Investigations | |
| February 7, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2019 | Not classified | Office of Inspections and Investigations | |
| December 16, 2016 | Not classified | Office of Inspections and Investigations | |
| May 15, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bora Pharmaceuticals (frmly: TWI Pharmaceuticals, Inc.)
- FDA Inspection 1305502 - 2026-03-27
- FDA Inspection 1119432 - 2020-02-07
- FDA Inspection 1103589 - 2019-08-23
- FDA Inspection 998389 - 2016-12-16
- FDA Inspection 881386 - 2014-05-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.